|
1
|
Cosentino M, Colombo C, Mauri M, Ferrari
M, Corbetta S, Marino F, Bono G and Lecchini S: Expression of
apoptosis-related proteins and of mRNA for dopaminergic receptors
in peripheral blood mononuclear cells from patients with Alzheimer
disease. Alzheimer Dis Assoc Disord. 23:88–90. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Moneim AE: Oxidant/antioxidant imbalance
and the risk of Alzheimer's disease. Curr Alzheimer Res.
12:335–349. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weinstein JD, Gonzalez ER, Egleton RD and
Hunt DA: A paradigm shift for evaluating pharmacotherapy for
Alzheimer's disease: The 10-patient screening protocol. Consult
Pharm. 28:443–454. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fan SH, Wang YY, Lu J, Zheng YL, Wu DM,
Zhang ZF, Shan Q, Hu B, Li MQ and Cheng W: CERS2 suppresses tumor
cell invasion and is associated with decreased V-ATPase and
MMP-2/MMP-9 activities in breast cancer. J Cell Biochem.
116:502–513. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang C, Chen L, Gu W, Du M, Li M, Chen Q
and Li D: Cyclosporin A enhances the ability of trophoblasts to
displace the activated human umbilical vein endothelial cell
monolayers. Int J Clin Exp Pathol. 6:2441–2450. 2013.PubMed/NCBI
|
|
6
|
Xie M, Hu A, Luo Y, Sun W, Hu X and Tang
S: Interleukin-4 and melatonin ameliorate high glucose and
interleukin-1β stimulated inflammatory reaction in human retinal
endothelial cells and retinal pigment epithelial cells. Mol Vis.
20:921–928. 2014.PubMed/NCBI
|
|
7
|
Zhang G, Liu D, Long G, Shi L, Qiu H, Hu
G, Hu G and Liu S: Downregulation of microRNA-181d had suppressive
effect on pancreatic cancer development through inverse regulation
of KNAIN2. Tumour Biol. 39:10104283176983642017.PubMed/NCBI
|
|
8
|
Wang J, Guo XJ, Ding YM and Jiang JX:
miR-1181 inhibits invasion and proliferation via STAT3 in
pancreatic cancer. World J Gastroenterol. 23:1594–1601. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lai X, Wang M, McElyea SD, Sherman S,
House M and Korc M: A microRNA signature in circulating exosomes is
superior to exosomal glypican-1 levels for diagnosing pancreatic
cancer. Cancer Lett. 393:86–93. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xia SS, Zhang GJ, Liu ZL, Tian HP, He Y,
Meng CY, Li LF, Wang ZW and Zhou T: MicroRNA-22 suppresses the
growth, migration and invasion of colorectal cancer cells through a
Sp1 negative feedback loop. Oncotarget. 8:36266–36278.
2017.PubMed/NCBI
|
|
11
|
Liu F, Liu B, Qian J, Wu G, Li J and Ma Z:
miR-153 enhances the therapeutic effect of gemcitabine by targeting
Snail in pancreatic cancer. Acta Biochim Biophys Sin (Shanghai).
49:520–529. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shigeyasu K, Toden S, Zumwalt TJ, Okugawa
Y and Goel A: Emerging role of microRNAs as liquid biopsy
biomarkers in gastrointestinal cancers. Clin Cancer Res.
23:2391–2399. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang BC and Ma J: Role of microRNAs in
malignant glioma. Chin Med J (Engl). 128:1238–1244. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tung SL, Huang WC, Hsu FC, Yang ZP, Jang
TH, Chang JW, Chuang CM, Lai CR and Wang LH: miRNA-34c-5p inhibits
amphiregulin-induced ovarian cancer stemness and drug resistance
via downregulation of the AREG-EGFR-ERK pathway. Oncogenesis.
6:e3262017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Su L, Gong YY, Ding ML, Hong SB, Yu
S and Xiao HP: Downregulation of miR-139-5p contributes to the
antiapoptotic effect of liraglutide on the diabetic rat pancreas
and INS-1 cells by targeting IRS1. PLoS One. 12:e01735762017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li L and Luo Z: Dysregulated miR-27a-3p
promotes nasopharyngeal carcinoma cell proliferation and migration
by targeting Mapk10. Oncol Rep. 37:2679–2687. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yarbro CH: International nursing and
breast cancer. Breast J. 9 Suppl 2:S98–S100. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu YF, Zhao Y, Wen XS and Dong QT:
Advances in research on pharmacodynamics and chemical conversion of
catalpol. Zhongguo Zhong Yao Za Zhi. 32:1128–1130. 2007.(In
Chinese). PubMed/NCBI
|
|
19
|
Wang K, Xie D, Xie J, Wan Y, Ma L, Qi X
and Yang S: MiR-27a regulates Wnt/beta-catenin signaling through
targeting SFRP1 in glioma. Neuroreport. 26:695–702. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Adams BD, Kasinski AL and Slack FJ:
Aberrant regulation and function of microRNAs in cancer. Curr Biol.
24:R762–R776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu F, Li J, Guo N, Wang XH and Liao YQ:
MiRNA-27a promotes the proliferation and invasion of human gastric
cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling
pathway. Am J Cancer Res. 7:405–416. 2017.PubMed/NCBI
|
